NeoFipronis (Miaite) User Guide and Medication Instructions
NeoFipronis (Pronidesivir) GS-441524, marketed under the brand name Miaite, is a groundbreaking oral treatment for Feline Infectious Peritonitis (FIP). Approved by the Lao Ministry of Agriculture and Forestry (MAF) in March 2026, NeoFipronis is the world’s first officially registered FIP medication with a dedicated registration number. It offers a safe, non-invasive, fast-acting, and well-tolerated therapy designed specifically for cats suffering from FIP symptoms.
FIP Symptoms Treated
NeoFipronis effectively addresses multiple symptoms associated with FIP, including loss of appetite, lethargy, fever, abdominal and thoracic fluid accumulation, lymphadenopathy, granulomatous inflammation, neurological injuries, and uveitis. Its targeted antiviral action against FIP virus makes it a vital option for feline health.
Active Ingredient and Efficacy
The active component in NeoFipronis is GS-441524, a nucleoside analog with proven antiviral capabilities. Extensive research and clinical trials have demonstrated its superior efficacy in inhibiting FIP virus replication, leading to significant remission rates in affected cats. The pharmacological profile ensures rapid absorption, quick onset of action, minimal side effects, and high tolerability.
Usage and Dosage
Administer NeoFipronis based on the cat’s weight. The standard dose is 15 mg per kilogram of body weight, roughly equivalent to half a tablet per dose. For cats with neurological or ocular FIP, dosage may be increased to 30 mg/kg, but always follow veterinarian’s instructions. The medication should be given once daily, ideally on an empty stomach—either an hour before feeding or two hours after feeding—to optimize absorption.
Treatment Duration
A minimum continuous treatment course of 12 weeks is crucial for effective recovery from FIP. Irregular or missed doses can compromise treatment outcomes. Owners should strictly adhere to the prescribed schedule, completing the full course unless otherwise advised by a veterinarian.
Monitoring and Precautions
Regular monitoring of the cat’s appetite, body temperature, and behavior is essential during treatment. Periodic blood tests should be conducted to assess liver and kidney function, ensuring the medication is well tolerated. While NeoFipronis is an over-the-counter drug, veterinary supervision is strongly recommended to optimize results and manage potential side effects.
Safety and Warnings
NeoFipronis (Pronidesivir) is intended solely for feline use. It is not suitable for humans or other animals. Always purchase the medication from official NeoFipronis verified sources or authorized distributors to ensure product authenticity and quality. Do not administer this medication without veterinary consultation, especially for cats with complex health conditions.
Storage and Purchase
Store NeoFipronis in a cool, dry place away from direct sunlight. Keep out of reach of children and pets. Visit the official NeoFipronis website or authorized veterinary pharmacies for purchasing options, ensuring authenticity and safety.
Final Notes
NeoFipronis promises a new hope for cats battling FIP. Its proven efficacy, safety profile, and ease of use make it an essential therapeutic option for feline owners and veterinarians. Proper adherence to dosage instructions, treatment duration, and veterinary guidance maximizes the chances of recovery from this challenging disease, improving the quality of life for affected cats.
